BioHarvest Sciences (XCNQ:BHSC) Cash-to-Debt : 0.24 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is BioHarvest Sciences Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. BioHarvest Sciences's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.24.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, BioHarvest Sciences couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for BioHarvest Sciences's Cash-to-Debt or its related term are showing as below:

XCNQ:BHSC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02 Med: 1.02 Max: No Debt
Current: 0.24

During the past 10 years, BioHarvest Sciences's highest Cash to Debt Ratio was No Debt. The lowest was 0.02. And the median was 1.02.

XCNQ:BHSC's Cash-to-Debt is ranked worse than
65.13% of 1784 companies
in the Consumer Packaged Goods industry
Industry Median: 0.52 vs XCNQ:BHSC: 0.24

BioHarvest Sciences Cash-to-Debt Historical Data

The historical data trend for BioHarvest Sciences's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

BioHarvest Sciences Cash-to-Debt Chart

BioHarvest Sciences Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

0.74

1.55

0.16

0.24

BioHarvest Sciences Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															0.29	0.16	0.04	0.14	0.24

Competitive Comparison of BioHarvest Sciences's Cash-to-Debt

For the Packaged Foods subindustry, BioHarvest Sciences's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioHarvest Sciences's Cash-to-Debt Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where BioHarvest Sciences's Cash-to-Debt falls into.

BioHarvest Sciences Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

BioHarvest Sciences's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	7.184	/	(28.061	+	1.912)
	=	0.24

BioHarvest Sciences's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	7.184	/	(28.061	+	1.912)
	=	0.24

BioHarvest Sciences (XCNQ:BHSC) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

BioHarvest Sciences Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

BioHarvest Sciences (XCNQ:BHSC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

CNVCF:USA 8MV:Germany

Address

1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6

Website

https://www.bioharvest.com

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

BioHarvest Sciences (XCNQ:BHSC) Headlines

No Headlines